Disability and disability-adjusted life years: Not the same

Public Health Reports

Volumn 124, Issue 2, 2009, Pages 197-202

  Grosse, Scott D ^a   Lollar, Donald J ^a   Campbell, Vincent A ^a   Chamie, Mary ^b  

^a NATIONAL CENTER ON BIRTH DEFECTS AND DEVELOPMENTAL DISABILITIES   (United States)

^b Population Associates Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAUSE OF DEATH; COST EFFECTIVENESS ANALYSIS; DISABILITY; DISEASE CLASSIFICATION; DISEASE SEVERITY; ECONOMIC EVALUATION; EVOLUTION; FUNCTIONAL STATUS; HEALTH CARE PERSONNEL; HEALTH CARE PRACTICE; HEALTH STATUS; HUMAN; LIFESPAN; LOWEST INCOME GROUP; MORBIDITY; PRIORITY JOURNAL; QUALITY OF LIFE; REVIEW; SOCIETY; UNITED STATES; WORLD HEALTH ORGANIZATION; CLASSIFICATION; COST OF ILLNESS; DISABLED PERSON; HOSPITALIZATION; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONAL COOPERATION; NOMENCLATURE; PUBLIC HEALTH SERVICE; QUALITY ADJUSTED LIFE YEAR; SICKNESS IMPACT PROFILE; STATISTICS;

COST OF ILLNESS; DISABLED PERSONS; HEALTH STATUS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; INTERNATIONALITY; PUBLIC HEALTH PRACTICE; QUALITY-ADJUSTED LIFE YEARS; SEVERITY OF ILLNESS INDEX; SICKNESS IMPACT PROFILE; TERMINOLOGY AS TOPIC;

EID: 65249101277     PISSN: 00333549     EISSN: 14682877     Source Type: Journal    
DOI: 10.1177/003335490912400206     Document Type: Review

References (52)

1. Mont D. Measuring health and disability. Lancet 2007;369:1658-1663 (Pubitemid 46711277)
2. Murray CJ, Acharya AK. Understanding DALYs (disability-adjusted life years). J Health Econ 1997;16:703-730
3. Murray CJL, Salomon JA, Mathers CD. A critical examination of summary measures of population health. In: Murray CJL, Salomon JA, Mathers CD, Lopez AD, editors. Summary measures of population health: concepts, ethics, measurement, and applications. Geneva: World Health Organization; 2002. p. 13-40.
4. Murray CJL, Lopez AD, editors. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries, and risk factors in 1990 and projected to 2020. Cambridge (MA): Harvard University Press; 1996.
5. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJL, editors. Global burden of disease and risk factors. Washington: World Bank; 2006.
6. Lopez AD, Mathers CD, Ezzati M, Jamison DT, Murray CJ. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006;367:1747-1757
7. Melse JM, Essink-Bot ML, Kramers PG, Hoeymans N. A national burden of disease calculation: Dutch disability-adjusted life-years. Dutch Burden of Disease Group. Am J Public Health 2000;90:1241-1247
8. Mathers CD, Vos ET, Stevenson CE, Begg SJ. The burden of disease and injury in Australia. Bull World Health Organ 2001;79:1076-1084 (Pubitemid 33078679)
9. Michaud CM, McKenna MT, Begg S, Tomijima N, Majmudar M, Bulzacchelli MT, et al. The burden of disease and injury in the United States, 1996. Popul Health Metr 2006;4:11.
10. Kominski GF, Simon PA, Ho A, Luck J, Lim YW, Fielding JE. Assessing the burden of disease and injury in Los Angeles County using disability-adjusted life years. Public Health Rep 2002;117:185-191 (Pubitemid 35192989)
11. Cadilhac DA, Carter RC, Thrift AG, Dewey HM. Why invest in a national public health program for stroke? An example using Australian data to estimate the potential benefits and cost implications. Health Policy 2007;83:287-294 (Pubitemid 47259212)
12. Gross CP, Anderson GF, Powe NR. The relation between funding by the National Institutes of Health and the burden of disease. N Engl J Med 1999;340:1881-1887 (Pubitemid 29272669)
13. Lamarre-Cliché M, Castilloux AM, LeLorier J. Association between the burden of disease and research funding by the Medical Research Council of Canada and the National Institutes of Health. A crosssectional study. Clin Invest Med 2001;24:83-89 (Pubitemid 32538893)
14. Aoun S, Pennebaker D, Pascal R. To what extent is health and medical research funding associated with the burden of disease in Australia? Aust N Z J Public Health 2004;28:80-86
15. Curry CW, De AK, Ikeda RM, Thacker SB. Health burden and funding at the Centers for Disease Control and Prevention. Am J Prev Med 2006;30:269-276 (Pubitemid 43221964)
16. Institute of Medicine; Committee to Evaluate Measures of Health Benefits for Environmental, Health, and Safety Regulation; Miller W, Robinson LA, Lawrence RS, editors. Valuing health for regulatory cost-effectiveness analysis. Washington: National Academies Press; 2006.
17. Schackman BR, Neukermans CP, Fontain SN, Nolte C, Joseph P, Pape JW, et al. Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med 2007;4:e183. (Pubitemid 46842584)
18. Sinha A, Levine O, Knoll MD, Muhib F, Lieu TA. Cost-effectiveness of pneumococcal conjugate vaccination in the prevention of child mortality: an international economic analysis. Lancet 2007;369:389-396 (Pubitemid 46177227)
19. Llanos A, Hertrampf E, Cortes F, Pardo A, Grosse SD, Uauy R. Cost-effectiveness of a folic acid fortification program in Chile. Health Policy 2007;83:295-303. (Pubitemid 47259210)
20. Tan-Torres Edejer T, Baltussen R, Adam T, Hutubessy R, Acharya A, Evans DB, et al., editors. Making choices in health: WHO guide to cost-effectiveness analysis. Geneva: World Health Organization; 2003. Also available from: URL: http://www.who.int/choice/publications/p-2003-generalised-cea.pdf [cited 2006 Mar 15].
21. Mathers CD, Vos T, Lopez AD, Salomon J, Ezzati M, editors. National burden of disease studies: a practical guide. Edition 2.0. Geneva: World Health Organization; 2001. Also available from: URL: http://www.who.int/healthinfo/ nationalburdenofdiseasemanual.pdf [cited 2006 Mar 15].
22. World Health Organization. International classification of functioning, disability and health (ICF) [cited 2008 Jul 2]. Available from: URL: http://www.who.int/classifications/icf/en
23. Chamie M. What does morbidity have to do with disability? Disabil Rehabil 1995;17:323-337
24. Groce NE, Chamie M, Me A. Measuring the quality of life: rethinking the World Bank's disability adjusted life years. Int Rehab Rev 1999;49:12-15
25. Jelsma J, De Weerdt W, De Cock P. Disability adjusted life years (DALYs) and rehabilitation. Disabil Rehabil 2002;24:378-382 (Pubitemid 34520715)
26. Fedeyko HJ, Lollar DJ. Classifying disability data. A fresh, integrative perspective. In: Altman BM, Barnartt SN, Hendershot G, Larson S, editors. Using survey data to study disability: results from the National Health Interview Survey on Disability, volume 3. London: JAI Press; 2003. p. 55-72.
27. World Bank. World development report 1993: investing in health. New York: Oxford University Press; 1993.
28. Jamison DT, Mosley WH, Measham AR, Bobadilla JL, editors. Disease control priorities in developing countries. 2nd ed. New York: Oxford University Press; 1994.
29. Murray CJ. Quantifying the burden of disease: the technical basis for disability-adjusted life years. Bull World Health Organ 1994;72:429-445 (Pubitemid 24234133)
30. Nord E. My goodness - and yours: a history, and some possible futures, of DALY meanings and valuation procedures. In: Murray CJL, Salomon JA, Mathers CD, Lopez AD, editors. Summary measures of population health: concepts, ethics, measurement and applications. Geneva: World Health Organization; 2002. p. 139-146
31. Arnesen T, Nord E. The value of DALY life: problems with ethics and validity of disability adjusted life years. BMJ 1999;319:1423-1425
32. Mansley EC, Elbasha EH. Preferences and person trade-offs: forcing consistency or inconsistency in health-related quality of life measures? Health Econ 2003;12:187-198
33. Sassi F. Calculating QALYs, comparing QALY and DALY calculations. Health Policy Plan 2006;21:402-408
34. Schwarzinger M, Stouthard ME, Burstrom K, Nord E. Cross-national agreement on disability weights: the European Disability Weights Project. Popul Health Metr 2003;1:9. (Pubitemid 39130385)
35. Schwarzinger M, Lanoe JL, Nord E, Durand-Zaleski I. Lack of multiplicative transitivity in person trade-off responses. Health Econ 2004;13:171-181 (Pubitemid 38208178)
36. Nord E. The desirability of a condition versus the well-being and worth of a person. Health Econ 2001;10:579-581 (Pubitemid 32998369)
37. Rock M. Discounted lives? Weighing disability when measuring health and ruling on "compassionate" murder. Soc Sci Med 2000;51:407-417
38. Fox-Rushby JA. Disability adjusted life years (DALYS) for decisionmaking? An overview of the literature. London: Office of Health Economics; 2002.
39. McKenna M, Marks J. Commentary on the uses of summary measures of population health. In: Murray CJL, Salomon JA, Mathers CD, Lopez AD, editors. Summary measures of population health: concepts, ethics, measurement and applications. Geneva: World Health Organization; 2002. p. 67-74.
40. Murray CJ, Lopez AD. Quantifying disability: data, methods and results. Bull World Health Organ 1994;72:481-494 (Pubitemid 24232514)
41. Mont D, Loeb M. Beyond DALYs: developing indicators to assess the impact of public health interventions on the lives of people with disabilities. SP Discussion Paper No. 0815. Washington: The World Bank; 2008.
42. Gilbert D. Stumbling on happiness. New York: Knopf; 2006.
43. Schwartz CE, Andresen EM, Nosek MA, Krahn GL. Response shift theory: important implications for measuring quality of life in people with disability. Arch Phys Med Rehabil 2007;88:529-536 (Pubitemid 46482431)
44. Andresen EM, Vahle VJ, Lollar D. Proxy reliability: health-related quality of life (HRQoL) measures for people with disability. Qual Life Res 2001;10:609-619 (Pubitemid 34056331)
45. Hays RD, Hahn H, Marshall G. Use of the SF-36 and other healthrelated quality of life measures to assess persons with disabilities. Arch Phys Med Rehabil 2002;83(12 Suppl 2):S4-9. (Pubitemid 35424683)
46. Sanders SJ. Depression cited as the top cause of medical disability. AMNews 2007 Apr 2 [cited 2008 Sep 28]. Available from: URL: http://www.ama-assn. org/amednews/2007/04/02/hlsb0402.htm
47. Thacker SB, Stroup DF, Carande-Kulis V, Marks JS, Roy K, Gerberding JL. Measuring the public's health. Public Health Rep 2006;121: 14-22. (Pubitemid 43200183)
48. Prevalence of disabilities and associated health conditions among adults - United States, 1999. MMWR Morb Mortal Wkly Rep 2001;50(7):120-125
49. Ozminkowski RJ, Burton WN, Goetzel RZ, Maclean R, Wang S. The impact of rheumatoid arthritis on medical expenditures, absenteeism, and short-term disability benefits. J Occup Environ Med 2006;48:135-148 (Pubitemid 43237945)
50. Arnesen T, Kapiriri L. Can the value choices in DALYs influence global priority-setting? Health Policy 2004;70:137-149
51. Stouthard MEA, Essink-Bot ML, Bonsel GJ, on behalf of the Dutch Disability Weights Group. Disability weights for diseases: a modified protocol and results for a Western European region. Eur J Public Health 2000;10:24-30.
52. Mathers C, Vos T, Stevenson C. The burden of disease and injury in Australia. Australian Institute of Health and Welfare. Canberra (Australia): AIHW; 1999. Also available from: URL: http://www.aihw.gov.au/publications/phe/ bdia/bdia.pdf [cited 2008 Jul 1].